Dendrimers are highly branched nanoparticles that are being explored in a variety of biomedical settings. They have been tested clinically to deliver chemotherapy and imaging agents, and are being tested preclinically with payloads that include small molecules and nucleic acids. (See BioWorld Today, March 18, 2009, and May 11, 2011.)